The past six decades have seen remarkable improvements in health outcomes for people
with cystic fibrosis, which was once a fatal disease of infants and young children. However, …

Context Early pulmonary infection in children with cystic fibrosis leads to increased morbidity
and mortality. Despite wide use of oropharyngeal cultures to identify pulmonary infection, …

… Catherine A Byrnes … 3 Chang AB, Bell SC, Byrnes CA, et al. Chronic suppurative lung
disease and bronchiectasis in children and adults in Australian and New Zealand. A position …

Background Indigenous children in high-income countries have a heavy burden of
bronchiectasis unrelated to cystic fibrosis. We aimed to establish whether long-term azithromycin …

With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific
patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 …

Objective Indigenous children in developed countries are at increased risk of chronic suppurative
lung disease (CSLD), including bronchiectasis. We evaluated sociodemographic and …

In March 2020, a national elimination strategy for coronavirus disease was introduced in New
Zealand. Since then, hospitalizations for lower respiratory tract infection among infants< 2 …

Background Newborn screening allows novel treatments for cystic fibrosis (CF) to be trialled
in early childhood before irreversible lung injury occurs. As respiratory exacerbations are a …

Background Although amoxicillin–clavulanate is the recommended first-line empirical oral
antibiotic treatment for non-severe exacerbations in children with bronchiectasis, azithromycin …

Background We describe Pseudomonas aeruginosa acquisitions in children with cystic
fibrosis (CF) aged ≤ 5-years, eradication treatment efficacy, and genotypic relationships …